Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Gopichand, Mamillapalli"'
Autor:
Naveen Reddy, Pramod Reddy, Ankit Ranpura, Narendra Maharaj, Rajendersingh Arora, Gopichand Mamillapalli, Aditya Shirish Adhav, Ashok Kumar Diwan, Alexey Manikhas, Dmitriy Krasnozhon
Publikováno v:
JCO Global Oncology, Vol , Iss 10 (2024)
PURPOSEDr Reddy's Laboratories Trastuzumab (DRL_TZ) is a biosimilar to Herceptin under development. The present study was conducted to evaluate efficacy, safety, pharmacokinetics (PKs), and immunogenicity of DRL_TZ in comparison with the reference me
Externí odkaz:
https://doaj.org/article/bba45b8803a44c0facf72a83a258f0a3
Autor:
Nagarkar, Rajnish (AUTHOR), Gopichand, Mamillapalli (AUTHOR), Pal, Suparna Kanti (AUTHOR), Gupta, Ankur (AUTHOR), Saquib, Najmuddin Mohd (AUTHOR), Sagar, Ganga (AUTHOR), Rao, Kanury VS (AUTHOR), Siddiqui, Zaved (AUTHOR), Longkumer, Imliwati (AUTHOR)
Publikováno v:
International Journal of Women's Health. Jan2024, Vol. 16, p1-7. 7p.
Autor:
Nagarkar, Rajnish, Gopichand, Mamillapalli, Pal, Suparna Kanti, Gupta, Ankur, Saquib, Najmuddin Md, Ahmad, Ahmad, Sagar, Ganga, Rao, Kanury V. S., Siddiqui, Zaved, Longkumer, Imliwati
Publikováno v:
Cancer Reports; Nov2024, Vol. 7 Issue 11, p1-12, 12p
Autor:
Sudeep Gupta, Ghanashyam Biswas, Suresh Babu, Tanveer M. Maksud, Kuntegowdennahalli C. Lakshmaiah, Jayanti G. Patel, Gopal Raja, Rakesh R. Boya, Pramod Patil, Kakali Choudhury, Shailesh A. Bondarde, Rakesh S. Neve, Guruprasad Bhat, Gopichand Mamillapalli, Apurva A. Patel, Piyush Patel, Nisarg Joshi, Vinay Bajaj, Mujtaba A. Khan
Publikováno v:
Breast, Vol 60, Iss , Pp 147-154 (2021)
Aim: To evaluate pharmacokinetics, efficacy and safety of fixed-dose combination (FDC) of oral capecitabine + cyclophosphamide in metastatic breast cancer (MBC) patients progressing after anthracycline and/or taxane chemotherapy. Methods: In this pro
Externí odkaz:
https://doaj.org/article/0b790ba06b124d0fa6988fc8cfbc4051
Autor:
Silvya Mathangi, Siva Reddy Challa, Naga Akhila Bhuvaneswari Kondru, Divya Arangi, Sri Lekhya Chowdary Kambham, Gopichand Mamillapalli, MV Subba Rao
Publikováno v:
Journal of Clinical and Diagnostic Research, Vol 13, Iss 10, Pp XC01-XC04 (2019)
Introduction: The status report on the global burden of cancer worldwide by the International Agency for Research on Cancer using GLOBOCAN 2018 estimated 18.1 million newer cancer cases and 9.6 million cancer deaths in 2018. Particularly, breast canc
Externí odkaz:
https://doaj.org/article/ad40cd6e81ee4afa8a53270b1d60e57a
Autor:
Ahmad, Ateeq, Sheikh, Saifuddin, Taran, Rakesh, Srivastav, Shanti P., Prasad, Krishna, Rajappa, Senthil J., Kumar, Vijay, Gopichand, Mamillapalli, Paithankar, Mahesh, Sharma, Manish, Rane, Rajendra C., Ahmad, Imran
Publikováno v:
In Clinical Breast Cancer June 2014 14(3):177-181
Autor:
Alexey Manikhas, Hans Friedrich Koch, Charuwan Akewanlop, Kakhaber Baramidze, Sirshendu Roy, Gopichand Mamillapalli, Ashwani Marwah, Virote Sriuranpong, Eduardo Yanez Ruiz, Miguel Hernandez-Bronchud, Unmesh Gopalakrishnan, Maria Luisa T. Abesamis-Tiambeng, Guzel Mukhametshina, Abhijit Barve, Joseph D. Parra, Adolfo Fuentes-Alburo, Ihor Vynnychenko, Sarika Deodhar, Gia Nemsadze, Igor Bondarenko, Eduardo J. Pennella, Cornelius F. Waller, Hope S. Rugo, Jay Herson, Subramanian Loganathan
Publikováno v:
Breast Cancer Research and Treatment
Breast cancer research and treatment, vol 188, iss 2
Breast cancer research and treatment, vol 188, iss 2
Purpose The phase 3 HERITAGE trial demonstrated that the biosimilar trastuzumab-dkst is well tolerated with similar efficacy (measured by overall response rate [ORR] and progression-free survival [PFS]) compared with originator trastuzumab combined w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d96d7db24623d3a61483158ddd9eb8f3
https://doi.org/10.1007/s10549-021-06197-5
https://doi.org/10.1007/s10549-021-06197-5
Autor:
Gopichand Mamillapalli, Ghanashyam Biswas, Guruprasad Bhat, Nisarg Joshi, Pramod Patil, Tanveer Maksud, Vinay Bajaj, Sudeep Gupta, Kakali Choudhury, Mujtaba A Khan, Suresh Babu, Gopal Raja, Apurva A. Patel, Jayanti G. Patel, Kuntegowdennahalli C. Lakshmaiah, Piyush M. Patel, Shailesh Arjun Bondarde, Rakesh R. Boya, Rakesh Neve
Publikováno v:
The Breast : Official Journal of the European Society of Mastology
Breast, Vol 60, Iss, Pp 147-154 (2021)
Breast, Vol 60, Iss, Pp 147-154 (2021)
Aim To evaluate pharmacokinetics, efficacy and safety of fixed-dose combination (FDC) of oral capecitabine + cyclophosphamide in metastatic breast cancer (MBC) patients progressing after anthracycline and/or taxane chemotherapy. Methods In this prosp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b12257f789ab2e767e0bbf5f06fe4775
https://pubmed.ncbi.nlm.nih.gov/34624757
https://pubmed.ncbi.nlm.nih.gov/34624757
Autor:
Ihor Vynnychenko, Virote Sriuranpong, Jinyu Yuan, Jay Herson, Eduardo Yanez Ruiz, Guzel Mukhametshina, Hope S. Rugo, Gia Nemsadze, Alexey Manikhas, Eduardo J. Pennella, Sirshendu Ray, Gopichand Mamillapalli, Igor Bondarenko, Kakhaber Baramidze, Charuwan Akewanlop, Mudgal Kothekar, Mark Baczkowski, Joseph D. Parra, Rajiv Sharma, Subramanian Loganathan, Miguel Hernandez-Bronchud, Cornelius F. Waller, Maria Luisa T. Abesamis-Tiambeng, Abhijit Barve
Publikováno v:
JAMA. 317(1)
Importance Treatment with the anti-ERBB2 humanized monoclonal antibody trastuzumab and chemotherapy significantly improves outcome in patients with ERBB2 (HER2)–positive metastatic breast cancer; a clinically effective biosimilar may help increase
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::90def91ec46cab4075076390dc4ef2a0
https://pubmed.ncbi.nlm.nih.gov/27918795
https://pubmed.ncbi.nlm.nih.gov/27918795
Autor:
E.P. Yanez Ruiz, Joseph D. Parra, Sirshendu Ray, Cornelius F. Waller, Alexey Manikhas, Eduardo J. Pennella, Maria Luisa T. Abesamis-Tiambeng, I. Bondarenko, Jinyu Yuan, Gopichand Mamillapalli, M.H. Bronchud, Abhijit Barve, Gia Nemsadze, Hope S. Rugo, Jay Herson, Ihor Vynnychenko, Kakhaber Baramidze, Guzel Mukhametshina, Virote Sriuranpong, C. Akewanlop
Publikováno v:
Annals of Oncology. 27:vi555
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3404d3fcce00a671e4bd4ef26f673470
https://doi.org/10.1093/annonc/mdw435.06
https://doi.org/10.1093/annonc/mdw435.06